Amyloid modifying brain agent medications can cause amyloid related imaging abnormalities due to brain edema, micro hemorrhages or macrohemorrhages in some patients.
Amyloid lowering agents anre often associated with loss of brain volume, worsening memory and functional abilities in some patients.